Rabbit Recombinant Multiclonal P53 phospho S376 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Dot | WB | |
---|---|---|
Human | Expected | Tested |
Synthetic peptide - Human | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info - | Notes - |
Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
TP53 phospho T377, TP53 phospho S392
P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53
Rabbit Recombinant Multiclonal P53 phospho S376 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
In Western blot, ab322465 was shown to bind specifically to TP53. Target of interest was observed at 35-53 kDa in wild-type HAP1 cell lysates (lane 1) with no signal observed at this size in TP53 knockout HAP1 cell line (lane 2).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-p53 antibody [Y5] (Anti-p53 antibody [Y5] ab32049) staining at 1/1000 dilution.
All lanes: Western blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (ab322465) at 1/1000 dilution
Lane 1: Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2: TP53 knockout HAP1 whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 53 kDa, 35-48 kDa, 36 kDa
Exposure time: 15s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-p53 antibody [Y5] (Anti-p53 antibody [Y5] ab32049) staining at 1/1000 dilution.
All lanes: Western blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (ab322465) at 1/1000 dilution
Lane 1: 293T (human embryonic kidney epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2: 293T whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 53 kDa, 35-48 kDa, 36 kDa
Exposure time: 10s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Negative control: HL-60 (p53 null), NCI-H1299 (p53 null).
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID: 21941372, PMID: 21779513, PMID: 25996291).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-p53 antibody [DO-1] - ChIP Grade (Anti-p53 antibody [DO-1] - ChIP Grade ab1101) staining at 1/1000 dilution.
In Western blot, Anti-p53 antibody [EPR17343] (Anti-p53 antibody [EPR17343] ab179477) staining at 1/1000 dilution.
All lanes: Western blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (ab322465) at 1/1000 dilution
Lane 1: Untreated HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HCT 116 treated with 20uM etoposide for 15 hours whole cell lysate at 20 µg
Lane 3: Untreated A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4: A549 treated with 500nM doxorubicin for 24 hours whole cell lysate at 20 µg
Lane 5: A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6: HL-60 (human acute promyelocytic leukemia promyeloblast) whole cell lysate at 20 µg
Lane 7: NCI-H1299 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 53 kDa, 26-48 kDa, 36 kDa
Exposure time: 10s
Dot blot analysis of TP53 (phospho S376+S377+S392) using ab322465 at 1:1000 dilution (0.499 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:100,000 dilution.
Lane1: Human p53(phospho S376) peptide
Lane2: Human p53(phospho T377) peptide
Lane3: Human p53(phospho S392) peptide
Lane4: Human p53 peptide
Exposure time: 6 seconds.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Dot Blot - Anti-TP53 (phospho S376+S377+S392) antibody [RM1161] (ab322465) at 1/1000 dilution
Lane 1: Human p53(phospho S376) peptide
Lane 2: Human p53(phospho T377) peptide
Lane 3: Human p53(phospho S392) peptide
Lane 4: Human p53 peptide
All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Exposure time: 6s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com